CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer.

Kessous, Roy; Wissing, Michel D; Piedimonte, Sabrina; Abitbol, Jeremie; Kogan, Liron; Laskov, Ido; Yasmeen, Amber; Salvador, Shannon; Lau, Susie; Gotlieb, Walter H

Kessous, Roy; Wissing, Michel D; Piedimonte, Sabrina; Abitbol, Jeremie; Kogan, Liron; Laskov, Ido; Yasmeen, Amber; Salvador, Shannon; Lau, Susie; Gotlieb, Walter H.

Afiliação

Kessous R; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Wissing MD; Department of Oncology, McGill University, Montreal, QC, Canada.
Piedimonte S; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Abitbol J; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Kogan L; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Laskov I; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Yasmeen A; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Salvador S; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Lau S; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Gotlieb WH; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.

Acta Obstet Gynecol Scand ; 99(7): 933-940, 2020 07.

Article em En | MEDLINE | ID: mdl-31954071

Assuntos

Antígeno Ca-125/metabolismo; Procedimentos Cirúrgicos de Citorredução; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/cirurgia; Idoso; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Biomarcadores Tumorais/metabolismo; Feminino; Humanos; Pessoa de Meia-Idade; Terapia Neoadjuvante; Gradação de Tumores; Estadiamento de Neoplasias; Neoplasias Ovarianas/mortalidade; Quebeque; Estudos Retrospectivos; Taxa de Sobrevida

Palavras-chave

CA-125; advanced ovarian cancer; neoadjuvant chemotherapy; primary debulking surgery

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Antígeno Ca-125 / Procedimentos Cirúrgicos de Citorredução Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Acta Obstet Gynecol Scand Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google